BR0000426A - Composição em forma de gel, creme, aerosol, spray, lìquida e liofilizada de substância carreadora de produtos à base de vitamina-e, papaìna e hialuronidase - Google Patents

Composição em forma de gel, creme, aerosol, spray, lìquida e liofilizada de substância carreadora de produtos à base de vitamina-e, papaìna e hialuronidase

Info

Publication number
BR0000426A
BR0000426A BR0000426-0A BR0000426A BR0000426A BR 0000426 A BR0000426 A BR 0000426A BR 0000426 A BR0000426 A BR 0000426A BR 0000426 A BR0000426 A BR 0000426A
Authority
BR
Brazil
Prior art keywords
hyaluronidase
papain
vitamin
aerosol
cream
Prior art date
Application number
BR0000426-0A
Other languages
English (en)
Other versions
BR0000426B1 (pt
Inventor
Cristiano Alberto Ribe Santana
Original Assignee
Cristiano Alberto Ribeiro Sant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristiano Alberto Ribeiro Sant filed Critical Cristiano Alberto Ribeiro Sant
Priority to BRPI0000426-0A priority Critical patent/BR0000426B1/pt
Priority to AT01901073T priority patent/ATE340588T1/de
Priority to PCT/BR2001/000011 priority patent/WO2001054647A2/en
Priority to CA2398723A priority patent/CA2398723C/en
Priority to AU26586/01A priority patent/AU2658601A/en
Priority to MXPA02007296A priority patent/MXPA02007296A/es
Priority to DE60123430T priority patent/DE60123430T2/de
Priority to PT01901073T priority patent/PT1303298E/pt
Priority to ES01901073T priority patent/ES2272435T3/es
Priority to EP01901073A priority patent/EP1303298B1/en
Priority to US10/182,265 priority patent/US20030049247A1/en
Publication of BR0000426A publication Critical patent/BR0000426A/pt
Publication of BR0000426B1 publication Critical patent/BR0000426B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<B>"COMPOSIçãO EM FORMA DE GEL, CREME, AEROSOL, SPRAY, LìQUIDA E LIOFILIZADA DE SUBSTâNCIA CARREADORA DE PRODUTOS à BASE DE VITAMINA-E, PAPAìNA E HIALURONIDASE"<D> O presente pedido de invenção refere-se a presente invenção à uma nova composição em forma de gel, creme, aerosol, spray líquida e liofilizada de substância carreadora de produtos a serem conjugados à base de vitamina-e, papaína e hialuronidase, com composição química: base anidro: POLIETILENO GLICOL 0,25g BUTIL PARABENO 0,01g PROPILENO GLICOL 0,20g óLEO MINERAL DESODORIZADO 0,16g EDTA SóDICO TETRA 0,002g TWEEN 80 0,40g PAPAìNA-6000 USP/MG 0,002g HIALURONIDASE 220 utr/mg VITAMINA E OLEOSA 0,020g
BRPI0000426-0A 2000-01-28 2000-01-28 Composição farmacêutica BR0000426B1 (pt)

Priority Applications (11)

Application Number Priority Date Filing Date Title
BRPI0000426-0A BR0000426B1 (pt) 2000-01-28 2000-01-28 Composição farmacêutica
AT01901073T ATE340588T1 (de) 2000-01-28 2001-01-25 Pharmazeutische zusammensetzung enthaltend träger für pharmakologisch aktive produkte wobei die träger auf vitamin e, papain und hyaluronidase basieren
PCT/BR2001/000011 WO2001054647A2 (en) 2000-01-28 2001-01-25 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase
CA2398723A CA2398723C (en) 2000-01-28 2001-01-25 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase
AU26586/01A AU2658601A (en) 2000-01-28 2001-01-25 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase
MXPA02007296A MXPA02007296A (es) 2000-01-28 2001-01-25 Composicion farmaceutica que comprende portadores para productos basados en vitamina 3, papaina e hialuronidasa.
DE60123430T DE60123430T2 (de) 2000-01-28 2001-01-25 Pharmazeutische zusammensetzung enthaltend träger für pharmakologisch aktive produkte wobei die träger auf vitamin e, papain und hyaluronidase basieren
PT01901073T PT1303298E (pt) 2000-01-28 2001-01-25 Composição farmacêutica compreendendo veículos para produtos farmacologicamente activos em que os veículos são baseados em vitamina e, papaína e hialuronidase
ES01901073T ES2272435T3 (es) 2000-01-28 2001-01-25 Composicion farmaceutica que comprende excipientes para productos farmacologiamente activos en la que los excipientes son a base de vitamin a e, papaina e hialuronidasa.
EP01901073A EP1303298B1 (en) 2000-01-28 2001-01-25 Pharmaceutical composition comprising carriers for pharmacologically active products wherein the carriers are based on vitamin-e, papain and hyaluronidase
US10/182,265 US20030049247A1 (en) 2000-01-28 2001-01-25 Pharmaceutical composition comprising carriers for products based on vitamin-e, pa pain and hyaluronidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0000426-0A BR0000426B1 (pt) 2000-01-28 2000-01-28 Composição farmacêutica

Publications (2)

Publication Number Publication Date
BR0000426A true BR0000426A (pt) 2001-09-18
BR0000426B1 BR0000426B1 (pt) 2014-09-30

Family

ID=36838693

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0000426-0A BR0000426B1 (pt) 2000-01-28 2000-01-28 Composição farmacêutica

Country Status (11)

Country Link
US (1) US20030049247A1 (pt)
EP (1) EP1303298B1 (pt)
AT (1) ATE340588T1 (pt)
AU (1) AU2658601A (pt)
BR (1) BR0000426B1 (pt)
CA (1) CA2398723C (pt)
DE (1) DE60123430T2 (pt)
ES (1) ES2272435T3 (pt)
MX (1) MXPA02007296A (pt)
PT (1) PT1303298E (pt)
WO (1) WO2001054647A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009100A (es) * 2001-04-06 2004-02-17 Cristiano Alberto Ribeiro Sant Composicion farmaceutica y procedimiento de obtencion respectivo.
BR0114991A (pt) * 2001-08-17 2003-11-04 Cristiano Alberto Ribe Santana Processo de obtenção de composição farmacêutica
WO2003018063A1 (en) * 2001-08-27 2003-03-06 Medtopic Empreendimentos E Particapações S/C Ltda. Composition of a carrier substance for products based on papain and hyaluronidase
BR0214242A (pt) * 2002-09-19 2004-09-21 Cristiano Alberto Ribe Santana Composição de substância carreadora de produtos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2973300A (en) * 1956-05-07 1961-02-28 American Home Prod Process for making antibiotic-enzyme topical film-forming compositions
US3887703A (en) * 1967-03-24 1975-06-03 Oreal Mucopolysaccharides, their preparation and use in cosmetic and pharmaceutical compositions
US4645668A (en) * 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
JP3249844B2 (ja) * 1992-01-31 2002-01-21 太陽化学株式会社 皮膚化粧料
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
BR9801985B1 (pt) * 1998-04-30 2011-12-27 composiÇço farmacÊutica de uso tàpico e respectivo processo de obtenÇço.
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Also Published As

Publication number Publication date
EP1303298A2 (en) 2003-04-23
ATE340588T1 (de) 2006-10-15
DE60123430T2 (de) 2007-08-23
BR0000426B1 (pt) 2014-09-30
CA2398723A1 (en) 2001-08-02
WO2001054647A2 (en) 2001-08-02
US20030049247A1 (en) 2003-03-13
AU2658601A (en) 2001-08-07
WO2001054647A3 (en) 2002-04-11
CA2398723C (en) 2013-08-20
ES2272435T3 (es) 2007-05-01
PT1303298E (pt) 2007-01-31
EP1303298B1 (en) 2006-09-27
MXPA02007296A (es) 2003-09-22
DE60123430D1 (de) 2006-11-09

Similar Documents

Publication Publication Date Title
DE60100866D1 (de) Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel
DE69922964D1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
BG103404A (en) Compositions containing antimycotic formulation and phospholipid
ATE345160T1 (de) Topisches produkt mit visuellem indikator
BR0005332A (pt) Aroma encapsulado
BR0000426A (pt) Composição em forma de gel, creme, aerosol, spray, lìquida e liofilizada de substância carreadora de produtos à base de vitamina-e, papaìna e hialuronidase
ES2147163A1 (es) Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
ITMI20020003A0 (it) Contenitore particolaremente studiato per creme cosmetiche e farmaceutiche
NZ506383A (en) A modified cream product comprising a gelling agent
BR0006503A (pt) Composição em forma de gel, creme, aerosol, spray, lìquida e liofilizada de substância carreadora de produtos à base de papaìna
ITMI20020194A0 (it) Contentitore per prodotti pastosi e cremosi in genere quali prodotti cosmetici farmaceutici e simili
IL128605A0 (en) Bottle for cosmetic and pharmaceutical products, hair dyes and the like, having separate components
PT1299114E (pt) Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
IT1299870B1 (it) Confezione, in particolare per il confezionamento di prodotti farmaceutici, procedimento da effettuare su tale confezione ed
FR2797397B1 (fr) Composition cosmetique liquide non aqueuse et article cosmetique la contenant
IT246800Y1 (it) Confezione multipla particolarmente per prodotti farmaceutici aridotto costo di produzione e ad elevata praticita&#39; di impiego
IT1303981B1 (it) Distribuzione di prodotti medicinali in polvere da assumere tramiteaspirazione.
ITMI20030442A1 (it) Struttura di etichetta autoadesiva per prodotti cosmetici in genere, ed in particolare per contenitori con ridotta superficie.
ITTO20040026A1 (it) Composizione di vernice con effetto riflettente, metodo per la sua applicazione e prodotti cosi&#39; ottenuti.
IT1296411B1 (it) Procedimento e impianto per la distribuzione di prodotti confezionati in particolare prodotti farmaceutici.
IT1320829B1 (it) Composizione di tintura sotto forma di gel, procedimento dipreparazione e confezione contenente la composizione.
IT1299869B1 (it) Confezione, in particolare per il confezionamento di prodotti farmaceutici, e macchina confezionatrice atta alla produzione di tale
BR0115182A (pt) Composição de substância carreadora de produtos à base de papaìna e hialuronidase
BR9902305A (pt) Tratamento sequencial para controle da dermatite seborrêica e recipiente para acondicionamento dos produtos utilizados
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BIOLAB SANUS FARMACEUTICA LTDA. (BR/SP)

Free format text: TRANSFERIDO DE: CRISTIANO ALBERTO RIBEIRO SANTANA

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O , 13 E 24 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/09/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2551 DE 26-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.